308080 Stock Chart & Stats
₩4555.00
-₩260.00(-5.40%)
―
--
Day’s Range― - ―
52-Week Range₩3,070.00 - ₩17,360.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)283.56K
Market Cap
₩98.70B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.99
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding20,499,260
10 Day Avg. Volume248,147
30 Day Avg. Volume283,560
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
308080 FAQ
What was ViGenCell, Inc.’s price range in the past 12 months?
ViGenCell, Inc. lowest stock price was ₩3070.00 and its highest was ₩17360.00 in the past 12 months.
What is ViGenCell, Inc.’s market cap?
ViGenCell, Inc.’s market cap is ₩98.70B.
When is ViGenCell, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ViGenCell, Inc.’s earnings last quarter?
ViGenCell, Inc. released its earnings results on May 14, 2026. The company reported -₩126.208 earnings per share for the quarter, missing the consensus estimate of N/A by -₩126.208.
Is ViGenCell, Inc. overvalued?
According to Wall Street analysts ViGenCell, Inc.’s price is currently Undervalued.
Does ViGenCell, Inc. pay dividends?
ViGenCell, Inc. does not currently pay dividends.
What is ViGenCell, Inc.’s EPS estimate?
ViGenCell, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ViGenCell, Inc. have?
ViGenCell, Inc. has 20,499,260 shares outstanding.
What happened to ViGenCell, Inc.’s price movement after its last earnings report?
ViGenCell, Inc. reported an EPS of -₩126.208 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.249%.
Which hedge fund is a major shareholder of ViGenCell, Inc.?
Currently, no hedge funds are holding shares in KR:308080
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
DongKoo Bio & Pharm Co. Ltd.
―
Genexine, Inc.
―
T&R Biofab Co., Ltd
―
TiumBio Co., Ltd.
―
Celemics, Inc.
―